Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29550782 | 1.00 | MEN1 (0.41) | MEN1KMT2AALDH1A1FKBP1AHSD17B10 | |
| SCHEMBL29550748 | 1.00 | MEN1 (0.41) | MEN1KMT2AALDH1A1FKBP1AHSD17B10 | |
| SCHEMBL5940491 | 1.00 | MEN1 (0.41) | MEN1KMT2AALDH1A1FKBP1AHSD17B10 | |
| SCHEMBL5742883 | 0.96 | MEN1 (0.43) | MEN1KMT2AALDH1A1FKBP1AHSD17B10 | |
| SCHEMBL20711832 | 0.96 | MEN1 (0.43) | MEN1KMT2AALDH1A1FKBP1AHSD17B10 | |
| SCHEMBL2453255 | 0.96 | MEN1 (0.43) | MEN1KMT2AALDH1A1FKBP1AHSD17B10 | |
| SCHEMBL5742885 | 0.96 | MEN1 (0.43) | MEN1KMT2AALDH1A1FKBP1AHSD17B10 | |
| SCHEMBL2054368 | 0.96 | MEN1 (0.43) | MEN1KMT2AALDH1A1FKBP1AHSD17B10 | |
| SCHEMBL25706923 | 0.91 | MEN1 (0.38) | MEN1KMT2AALDH1A1HSD17B10L3MBTL1 | |
| SCHEMBL26547622 | 0.89 | MEN1 (0.42) | MEN1KMT2AALDH1A1HSD17B10L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060178359-A1 | Tricyclic compound, process for producing the same, and use | SYNGENTA CROP PROTECTION AG (CH) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178359-A1 | Tricyclic compound, process for producing the same, and use | CCR4, CCR5, CCR1 | MEN1 3723/4885KMT2A 1800/4885ALDH1A1 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.